The store will not work correctly when cookies are disabled.
Methyl 3-(4-(tert-butyl)benzamido)-5-chloropicolinate
ID: ALA4740530
PubChem CID: 162644970
Max Phase: Preclinical
Molecular Formula: C18H19ClN2O3
Molecular Weight: 346.81
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: COC(=O)c1ncc(Cl)cc1NC(=O)c1ccc(C(C)(C)C)cc1
Standard InChI: InChI=1S/C18H19ClN2O3/c1-18(2,3)12-7-5-11(6-8-12)16(22)21-14-9-13(19)10-20-15(14)17(23)24-4/h5-10H,1-4H3,(H,21,22)
Standard InChI Key: OOCRBEIXCQFAPS-UHFFFAOYSA-N
Molfile:
RDKit 2D
24 25 0 0 0 0 0 0 0 0999 V2000
14.1962 -14.9075 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.1951 -15.7270 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.9031 -16.1360 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.6128 -15.7266 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.6100 -14.9039 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.9014 -14.4987 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.9029 -16.9532 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.1951 -17.3616 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
15.6106 -17.3620 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
16.3212 -16.1341 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
17.0282 -15.7244 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.7366 -16.1318 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.0269 -14.9072 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
17.7332 -16.9475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.4407 -17.3549 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.1488 -16.9451 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.1449 -16.1237 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.4368 -15.7200 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.8577 -17.3517 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.8600 -18.1689 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.5642 -16.9410 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.5619 -17.7595 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.4875 -16.9529 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.8989 -13.6815 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
3 7 1 0
7 8 1 0
7 9 2 0
4 10 1 0
10 11 1 0
11 12 1 0
11 13 2 0
12 14 2 0
14 15 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 12 1 0
16 19 1 0
19 20 1 0
19 21 1 0
19 22 1 0
8 23 1 0
6 24 1 0
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 346.81 | Molecular Weight (Monoisotopic): 346.1084 | AlogP: 4.07 | #Rotatable Bonds: 3 |
Polar Surface Area: 68.29 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 0.74 | CX LogP: 4.84 | CX LogD: 4.84 |
Aromatic Rings: 2 | Heavy Atoms: 24 | QED Weighted: 0.85 | Np Likeness Score: -1.50 |
References
1. Khalifa MM,Martorelli Di Genova B,McAlpine SG,Gallego-Lopez GM,Stevenson DM,Rozema SD,Monaghan NP,Morris JC,Knoll LJ,Golden JE. (2020) Dual-Stage Picolinic Acid-Derived Inhibitors of Toxoplasma gondii., 11 (12): [PMID:33335660] [10.1021/acsmedchemlett.0c00267] |